{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:26:59Z","timestamp":1793809619457,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymthe.2026.08.035","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:03:32Z","timestamp":1787673812000},"page":"6275-6293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-terminal CD28 phosphorylation, pY218, modulates IL-2 secretion and therapeutic effect of CAR-T cells"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3220-5395","authenticated-orcid":false,"given":"Elena","family":"Martinez-Planes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cecilia","family":"Ramello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel G.","family":"Fontela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1342-7620","authenticated-orcid":false,"given":"Timothy H.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lancia","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngchul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Abate-Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.035_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(00)80901-0","article-title":"LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.035_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2000.63.re1","article-title":"LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways","volume":"2000","author":"Wange","year":"2000","journal-title":"Sci. STKE."},{"key":"10.1016\/j.ymthe.2026.08.035_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.immunol.19.1.497","article-title":"Calcium signaling mechanisms in T lymphocytes","volume":"19","author":"Lewis","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib7","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.4049\/jimmunol.174.10.6233","article-title":"A new tyrosine phosphorylation site in PLC gamma 1: the role of tyrosine 775 in immune receptor signaling","volume":"174","author":"Serrano","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002436","article-title":"An enigmatic tail of CD28 signaling","volume":"2","author":"Boomer","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 Costimulation: From Mechanism to Therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.035_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aap9777","article-title":"An immunoproteomic approach to characterize the CAR interactome and signalosome","volume":"12","author":"Ramello","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2026.08.035_bib11","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-09-3169","article-title":"Prostate stem cell antigen: a Jekyll and Hyde molecule?","volume":"16","author":"Saeki","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of Interleukin-2 in T Lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: a protein-protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2026.08.035_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1084\/jem.20090880","article-title":"Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance","volume":"207","author":"Fu","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib15","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.0902876","article-title":"The role of the LAT-PLC-gamma1 interaction in T regulatory cell function","volume":"184","author":"Chuck","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1245\/s10434-015-4923-3","article-title":"A High ROR\u03b3T\/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)","volume":"23","author":"Yoshida","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3892\/mmr.2012.1036","article-title":"Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer","volume":"6","author":"Du","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2026.08.035_bib18","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1158\/2326-6066.CIR-23-0527","article-title":"Pancreatic Epithelial IL17\/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis","volume":"12","author":"Castro-Pando","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.035_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib22","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/bjh.16406","article-title":"The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity","volume":"189","author":"Godwin","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12551-012-0081-z","article-title":"SH3 domains: modules of protein-protein interactions","volume":"5","author":"Kurochkina","year":"2013","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ymthe.2026.08.035_bib24","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1074\/jbc.271.41.25646","article-title":"Identification of Itk\/Tsk Src homology 3 domain ligands","volume":"271","author":"Bunnell","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.08.035_bib25","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1074\/jbc.RA119.008318","article-title":"The SH3 domains of the protein kinases ITK and LCK compete for adjacent sites on T cell-specific adapter protein","volume":"294","author":"Andersen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.08.035_bib26","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/MCB.01657-09","article-title":"In vivo significance of ITK-SLP-76 interaction in cytokine production","volume":"30","author":"Grasis","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-024-03315-3","article-title":"Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2026.08.035_bib28","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41467-017-01867-9","article-title":"Human CD26(high) T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence","volume":"8","author":"Bailey","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.035_bib29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1368732","article-title":"Prospects and challenges of CAR-T cell therapy combined with ICIs","volume":"14","author":"Lv","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib31","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.08.035_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib33","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.18632\/oncotarget.24442","article-title":"IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner","volume":"9","author":"Loschinski","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2026.08.035_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.omto.2017.12.003","article-title":"CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity","volume":"8","author":"Kueberuwa","year":"2018","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2026.08.035_bib36","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/s41467-019-11869-4","article-title":"CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors","volume":"10","author":"Jin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.035_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1049","article-title":"Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations","volume":"8","author":"Weinkove","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.08.035_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib40","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1158\/1078-0432.CCR-17-1788","article-title":"Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice","volume":"24","author":"Gulati","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/mt.2011.9","article-title":"CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation","volume":"19","author":"Kofler","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.035_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2326-6066.CIR-20-0253","article-title":"CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function","volume":"9","author":"Boucher","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib43","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI133215","article-title":"Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability","volume":"130","author":"Guedan","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.08.035_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2026.08.035_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20062066","article-title":"A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76","volume":"204","author":"Di Bartolo","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib46","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1158\/0008-5472.CAN-15-0054","article-title":"IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment","volume":"75","author":"Benevides","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib47","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","article-title":"Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis","volume":"41","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.035_bib48","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1073\/pnas.1319051111","article-title":"T helper 17 cells play a critical pathogenic role in lung cancer","volume":"111","author":"Chang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.035_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-15-0154","article-title":"IL17A-Mediated Endothelial Breach Promotes Metastasis Formation","volume":"4","author":"Kulig","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.08.035_bib50","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.08.035_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167159","article-title":"Armed with IL-2 based fusion protein improves CAR-T cell fitness and efficacy against solid tumors","volume":"1870","author":"Li","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2026.08.035_bib52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.035_bib53","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.035_bib54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2013.209","article-title":"A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer","volume":"25","author":"Abate-Daga","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.08.035_bib55","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","article-title":"An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database","volume":"5","author":"Eng","year":"1994","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ymthe.2026.08.035_bib56","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ymthe.2026.08.035_bib57","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.035_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.035_bib59","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.08.035_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2026.08.035_bib61","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/prot.21723","article-title":"HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets","volume":"69","author":"de Vries","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.ymthe.2026.08.035_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.035_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.035_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.08.035_bib65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:58:35Z","timestamp":1793807915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1525001626007161"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-terminal CD28 phosphorylation, pY218, modulates IL-2 secretion and therapeutic effect of CAR-T cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}